MMP2 and nasopharyngeal carcinoma: The ability of ISL to suppress NPC cell migration and invasion, at least partially through the inhibition of the STAT3/MMP‐2 axis, provides a rationale for further evaluation of this compound in preclinical model of metastatic NPC.